共 57 条
[1]
Herbst C(2009)Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy Cochrane Database Syst Rev 1 CD007107-2453
[2]
Naumann F(2006)European organisation for research and treatment of cancer (EORTC) granulocyte colony-stimulating factor (G-CSF) guidelines working party. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours Eur J Cancer 42 2433-10
[3]
Kruse EB(2009)Prevention of febrile neutropenia: use of granulocyte colony stimulating factors Br J Cancer 101 6-541
[4]
Aapro MS(2010)Prophylaxis of chemotherapy induced febrile neutropenia with granulocyte colony stimulating factors: where are we know? Support Care Cancer 18 549-727
[5]
Cameron DA(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719-4274
[6]
Pettengell R(2005)Randomised phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with epidermal growth factor receptor-2 positive metastatic breast cancer administered as first line treatment. The M77001 Study Group J Clin Oncol 23 4265-3205
[7]
Kelly S(2006)2006 update of the recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline J Clin Oncol 24 3187-437
[8]
Wheatley D(2005)Risk models for chemotherapy-induced neutropenia Oncologist 10 427-374
[9]
Aapro M(2008)Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model Am J Clin Oncol 31 369-685
[10]
Crawford J(2009)Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU prospective observational European Neutropenia Study Br J Haematol 144 677-762